HOME > ARCHIVE
ARCHIVE
- Generics Account for 10.1% of Cost of Drugs in Non-legal Rx Issued by Clinics
September 4, 2006
- SURVEY 4 articles
September 4, 2006
- GENERIC NEWS IN BRIEF Korosho's FY2007 Budget to Promote Use of GE Drugs
September 4, 2006
- Eight APIs Recommended for Approval
September 4, 2006
- 1/3 of Drug-Related Accidents Are Due to Wrong Dosage: JCQHC
September 4, 2006
- RAPS to Initiate Training Program for Regulatory Affairs Professionals
September 4, 2006
- Results of Two Studies Announced by JPA
September 4, 2006
- Nichiiren to Support Mr Takemi in Next Election of Upper House
September 4, 2006
- Next Medical Fee Revision "Won't Be Too Severe": Prof. Nishimura
September 4, 2006
- REGULATORY NEWS IN BRIEF
September 4, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 4, 2006
- Direct Deal between Makers, Med. Institutions Conditionally Approvable: Mr Katagiri of FTC
September 4, 2006
- MEDICAL DEVICE NEWS IN BRIEF
September 4, 2006
- Blopress Top-selling Drug in April-June: IMS Japan
September 4, 2006
- SELF-MEDICATION NEWS IN BRIEF
September 4, 2006
- Drug Wholesalers' Gross Profit Ratio Hits Record Low: FJPWA
September 4, 2006
- FPMAJ to Propose System That May Raise NHI Prices of Existing Drugs: Mr Nagano
September 4, 2006
- DSP, Sumitomo Chemical Agree with Pfizer on Settlement of Amlodin Lawsuit
September 4, 2006
- BUSINESS NEWS IN BRIEF
September 4, 2006
- NEW PRODUCTS
September 4, 2006
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
